Company: TGNT
Filing Date: 2025-05-07
Form Type: S-1/A
Source: 0001477932-25-003416
Chunk: 16

Company: Totaligent, Inc.
Filing Date: 2025-05-07
Form: S-1/A
Chunk 16
---
 such sales could occur, could adversely affect the market price of our common stock.                                                                         |
| ● | Shares eligible for future sale may have adverse effects on our share price.                                                                                                                                                                                                                                                                                                         |
| ● | Future sales of additional shares of our Common Stock or securities convertible into shares of our Common Stock may dilute our shareholders’ ownership in us and may adversely affect us or the trading price of our Common Stock.                                                                                                                                                   |
| ● | Future sales of shares of our Common Stock could lower the trading price of our Common Stock, and any additional capital raised by us through the sale of additional equity including pursuant to the SEPA or convertible debt securities may dilute our shareholders’ ownership in us and may adversely affect us or the trading price of our Common Stock.                         |
| ● | The loss of liquidity could adversely impact a stockholder’s ability to sell Shares.                                                                                                                                                                                                                                                                                                 |

| 15 |

Corporate Information

Totaligent, Inc. is a Delaware corporation. Our Common Stock is quoted on the OTC Pink Market under the ticker symbol “TGNT”.

As of April 25, 2025, there are 211,251,063 shares of Common Stock issued and outstanding and 576,562 shares of Series D Preferred Stock, which are convertible into 576,562,000 shares of Common Stock. Edward DeFeudis, our Chief Executive Officer, owns directly and indirectly 139,000 shares of our Series D Preferred Stock and 13,276,086 shares of our Common Stock, which represents in the aggregate 19.33% of the Company’s Capital Stock on a fully diluted basis. (See, “Description of Securities” for additional information about our securities).

Our principal executive office and mailing address is 3651 FAU Blvd., Suite 400 Boca Raton, FL 33431. Our telephone number is (561) 360-3565. Our corporate website is https://www.totaligent.com/. The information contained on, or that can be accessed through, our website is not part of, and is not incorporated by reference into, this prospectus and should not be relied upon with respect to this offering.

<div align='center'>TheOffering</div>

The following Summary contains general information about this offering. The Summary is not intended to be complete. You should read the full text and more specific details contained elsewhere in this prospectus.

| Common Stock to be offered by Selling Stockholder |     | Up to 100,000,000 shares, consisting of (i)